New drug trial aims to protect kidneys from silent disease
NCT ID NCT04716231
Summary
This study is testing whether a drug called atacicept can help control IgA nephropathy, a kidney disease. It will see if the drug safely reduces protein in the urine and slows the decline of kidney function in adults who are already on standard medication. The trial involves a two-year treatment period followed by monitoring to assess long-term effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ORIGIN 3 Global Site Contact Information
Brisbane, California, 94005, United States
Conditions
Explore the condition pages connected to this study.